Results 61 to 70 of about 3,178,532 (212)

Simultaneous liquid-chromatographic determination of some bronchodilators, anticonvulsants, chloramphenicol, and hypnotic agents, with Chromosorb P columns used for sample preparation. [PDF]

, 1989
Dobrin Svinarov, D C Dotchev
openalex   +1 more source

Reducing cholinergic constriction: the major reversible mechanism in COPD

European Respiratory Review, 2006
The airway narrowing in chronic obstructive pulmonary disease (COPD) has often been misunderstood as being irreversible. However, a large proportion of patients with COPD do respond to bronchodilator agents with significant changes in lung function ...
V. Brusasco
doaj  

Pharmacodynamics of a bronchodilator agent DO-309 in its repetitive admimistration test.

, 1994
Eiji Uchida
openalex   +2 more sources

Anticholinergic bronchodilators versus beta2-sympathomimetic agents for acute exacerbations of chronic obstructive pulmonary disease

, 2003
Douglas C McCrory, Cynthia D. Brown
openalex   +2 more sources

Methacholine challenge testing: comparative pharmacology

Journal of Asthma and Allergy, 2018
Beth E Davis, Christianne M Blais, Donald W Cockcroft Division of Respirology, Critical Care and Sleep Medicine, Department of Medicine, University of Saskatchewan, Saskatoon, SK, Canada Abstract: Standardization of the methacholine inhalation challenge,
Davis BE, Blais CM, Cockcroft DW
doaj  

Efficacy of tiotropium and indacaterol monotherapy and their combination on dynamic lung hyperinflation in COPD: a random open-label crossover study

International Journal of COPD, 2017
Keisaku Fujimoto,1 Haruna Yamazaki,2 Midori Ura,2 Yoshiaki Kitaguchi3 1Department of Clinical Laboratory Sciences, School of Health Sciences, 2Department of Biomedical Laboratory Science, Graduate School of Medicine, 3First Department of Internal ...
Fujimoto K, Yamazaki H, Ura M, Kitaguchi Y   +3 more
doaj  

Pharmacodynamic dose-escalating study of bronchodilator agent DO-309 in healthy person effect of meal and smoking.

, 1993
EIJI UCHIDA
openalex   +2 more sources

Soluble guanylate cyclase as an alternative target for bronchodilator therapy in asthma

Proceedings of the National Academy of Sciences of the United States of America, 2016
Arnab Ghosh, C. Koziol-White, K. Asosingh, Georgina Cheng, Lisa M Ruple, D. Groneberg, A. Friebe, S. Comhair, J. Stasch, R. Panettieri, M. Aronica, S. Erzurum, D. Stuehr   +12 more
semanticscholar   +1 more source

Health resource utilization for inpatients with COPD treated with nebulized arformoterol or nebulized formoterol

International Journal of COPD, 2017
Vaidyanathan Ganapathy,1 Michael D Stensland2 1Sunovion Pharmaceuticals Inc., Marlborough, MA, 2Agile Outcomes Research, Inc., Rochester, MN, USA Objective: Arformoterol is the (R,R)-enantiomer of formoterol.
Ganapathy V, Stensland MD
doaj  

Bronchodilator effects of ipratropium bromide and albuterol sulfate among subjects with tetraplegia

Journal of Spinal Cord Medicine (JSCM), 2018
G. Schilero, Joshua C. Hobson, Kamaldeep Singh, A. Spungen, W. Bauman, Miroslav Radulovic   +5 more
semanticscholar   +1 more source